Document is current
Any future updates will be listed below
-
Authors
Gaggi, Naomi L.
Parincu, Zamfira
Siu, Kari
Collins, Katherine A.
Iosifescu, Dan V.
-
Funding
Funding for this research was provided by:
National Institute on Mental Health (R61/R33MH122647, R61/R33MH122647, R61/R33MH122647)
- License Information
-
More Information
Article History
Accepted: 8 May 2024
First Online: 11 June 2024
Compliance with Ethical Standards
:
: All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines). Dr. Katherine A. Collins serves as a consultant for Cronos Clinical Consulting, Inc., and Relmada Therapeutics. In the last 10 years, Dr. Dan V. Iosifescu has served as a consultant for Alkermes, Allergan, Angelini, Autobahn, Axsome, Biogen, Boehringer Ingelheim, the Centers for Psychiatric Excellence, Clexio, Delix, Jazz, Lundbeck, Neumora, Otsuka, Precision Neuroscience, Relmada, Sage Therapeutics, and Sunovion. Dr. Dan V. Iosifescu has received grant support (paid to his institutions) from Alkermes, AstraZeneca, BrainsWay, LiteCure, NeoSync, Otsuka, Roche, and Shire. All other co-authors do not have any conflicts of interest unless otherwise stated.
